<DOC>
	<DOC>NCT00467935</DOC>
	<brief_summary>This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.</brief_summary>
	<brief_title>Scotoma Reduction in AMD Patients Treated With Ranibizumab</brief_title>
	<detailed_description>Patients with severe wet macular degeneration and scarring in the center of the retina may benefit from treatment if the size of the blind spot is reduced wiht injections of Lucentis.</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Scotoma</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>BCVA &lt; 20/320 Disciform macular degeneration wiht exudation Nonamd CNV</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>amd</keyword>
	<keyword>disciform</keyword>
	<keyword>fibrosis</keyword>
	<keyword>Lucentis</keyword>
	<keyword>scotoma</keyword>
</DOC>